Chemoprevention strategies for pancreatic cancer

被引：102

作者：

Stan, Silvia D. ^{[1
]}

Singh, Shivendra V. ^{[2
]}

Brand, Randall E. ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Med,Hillman Canc Ctr 2 31, Pittsburgh, PA 15213 USA

[2] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Hillman Canc Ctr 2 31, Pittsburgh, PA 15213 USA

来源：

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2010年 / 7卷 / 06期

关键词：

FACTOR-KAPPA-B; CELL-CYCLE ARREST; GREEN TEA CONSUMPTION; I CLINICAL-TRIAL; VITAMIN-D; BENZYL ISOTHIOCYANATE; PERILLYL ALCOHOL; GROWTH-FACTOR; CYCLOOXYGENASE-2; EXPRESSION; EPIGALLOCATECHIN GALLATE;

D O I：

10.1038/nrgastro.2010.61

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pancreatic cancer has a poor prognosis and is often diagnosed at an advanced stage, which makes it difficult to treat. The low survival rate of patients with pancreatic cancer points towards an increased need for novel therapeutic and chemopreventive strategies and also early detection of this disease. Increased consumption of fruits and vegetables has been associated with a reduced risk of pancreatic cancer. Synthetic and natural, diet-derived bioactive compounds have been evaluated as pancreatic cancer chemopreventive agents and have demonstrated various degrees of efficacy in cellular and in vivo animal models. Some chemopreventive agents (for example, curcumin or resveratrol) have also been reported to sensitize pancreatic cancer cells to standard chemotherapeutic drugs (for example, gemcitabine or erlotinib), which suggests that chemopreventive agents could potentially be used as potentiators of standard chemotherapy. Few clinical trials of pancreatic cancer chemopreventive agents have been completed and some are in early phases. Further development of pancreatic cancer chemopreventive agents may prove to be tremendously valuable for individuals at high risk of developing pancreatic cancer and patients who present with premalignant lesions. This Review discusses the current state of the pancreatic cancer chemoprevention field and highlights the challenges ahead.

引用

页码：347 / 356

页数：10

共 121 条

[1] Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer - Modern target but ancient solution [J].

Aggarwal, Bharat B. ;

Sethi, Gautam ;

Ahn, Kwang Seok ;

Sandur, Santosh K. ;

Pandey, Manoj K. ;

Kunnumakkara, Ajaikumar B. ;

Sung, Bokyung ;

Ichikawa, Haruyo .

SIGNAL TRANSDUCTION PATHWAYS, PT B: STRESS SIGNALING AND TRANSCRIPTIONAL CONTROL, 2006, 1091 :151-169

[2] RETRACTED: Apoptosis-inducing effect of erlotinib is potentiated by 3,3′-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer (Retracted article. See vol. 17, pg. 2266, 2018) [J].

Ali, Shadan ;

Banerjee, Sanjeev ;

Ahmad, Aamir ;

El-Rayes, Bassel F. ;

Philip, Philip A. ;

Sarkar, Fazlul H. .

MOLECULAR CANCER THERAPEUTICS, 2008, 7 (06) :1708-1719

[3]

Anderson KE, 2002, J NATL CANCER I, V94, P1168, DOI 10.1093/jnci/94.15.1168

[4] INHIBITORY EFFECTS OF MICRONUTRIENTS ON PANCREATIC CARCINOGENESIS IN AZASERINE-TREATED RATS [J].

APPEL, MJ ;

ROVERTS, G ;

WOUTERSEN, RA .

CARCINOGENESIS, 1991, 12 (11) :2157-2161

[5] Chemoprevention of Pancreatic Cancer: Characterization of Par-4 and its Modulation by 3,3' Diindolylmethane (DIM) [J].

Azmi, Asfar Sohail ;

Ahmad, Aamir ;

Banerjee, Sanjeev ;

Rangnekar, Vivek M. ;

Mohammad, Ramzi M. ;

Sarkar, Fazlul H. .

PHARMACEUTICAL RESEARCH, 2008, 25 (09) :2117-2124

[6] Pancreatic cancer biology and genetics [J].

Bardeesy, N ;

DePinho, RA .

NATURE REVIEWS CANCER, 2002, 2 (12) :897-909

[7] Anti-proliferative and proapoptotic effects of benzyl isothiocyanate on human pancreatic cancer cells is linked to death receptor activation and RasGAP/Rac1 down-modulation [J].

Basu, Aruna ;

Haldar, Subrata .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (03) :593-599

[8] Advances in counselling and surveillance patients at risk for pancreatic cancer [J].

Brand, Randall E. ;

Lerch, Markus M. ;

Rubinstein, Wendy S. ;

Neoptolemos, John P. ;

Whitcomb, David C. ;

Hruban, Ralph H. ;

Brentnall, Teresa A. ;

Lynch, Henry T. ;

Canto, Marcia I. .

GUT, 2007, 56 (10) :1460-1469

[9] Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol [J].

Burke, YD ;

Stark, MJ ;

Roach, SL ;

Sen, SE ;

Crowell, PL .

LIPIDS, 1997, 32 (02) :151-156

[10] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].

Burris, HA ;

Moore, MJ ;

Andersen, J ;

Green, MR ;

Rothenberg, ML ;

Madiano, MR ;

Cripps, MC ;

Portenoy, RK ;

Storniolo, AM ;

Tarassoff, P ;

Nelson, R ;

Dorr, FA ;

Stephens, CD ;

VanHoff, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413

← 1 2 3 4 5 6 7 8 9 10 →